Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04941677
Other study ID # B-ER-109-188
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 17, 2020
Est. completion date December 31, 2022

Study information

Verified date April 2024
Source National Cheng-Kung University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The study aims to explore the hand function in people with schizophrenia in the chronic stage.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date December 31, 2022
Est. primary completion date July 31, 2022
Accepts healthy volunteers
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: - Age between 20-65 years old - Diagnosis with schizophrenia or schizoaffective disorder by psychiatrists according to DSM5. - Remaining the same antipsychotics and the symptom was stable for at least one month before the study. - Be able to follow comments and have sufficient cognitive ability assessed by Mini-Mental State Examination score >24 Exclusion Criteria: - Substance abuse or other medical conditions that may affect movements. - Using other non-antipsychotics that will affect movements in the same period.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention in this study

Locations

Country Name City State
Taiwan National Cheng-Kung University Tainan

Sponsors (1)

Lead Sponsor Collaborator
National Cheng-Kung University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Semmes Weinstein Monofilaments Semmes Weinstein Monofilaments is used to assess cutaneous pressure thresholds. baseline
Primary Pinch-holding-up-activity test The pinch apparatus is aims to assess the ability to modulate pinch force to movement-induced load fluctuations in a pinch-holding-up activity (PHUA). baseline
Primary Manual Tactile Test Manual tactile test (MTT) aims to assess the capacity of barognosis, roughness differentiation and stereognosis. baseline
Primary Purdue pegboard test The purpose for Purdue pegboard test is to measure manipulative dexterity including unimanual and bimanual hand dexterity. baseline
Primary The Valpar 8 simulates assembly work assessment Valpar8 simulates the light work and assess the ability of manual dexterity and motor coordination. baseline
Secondary Self-reported version of the graphic Personal and Social Performance (SRG-PSP) The self-reported version of the graphic personal and social performance is a self-report scale that aims to assess functional performance. baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A